ArticlePDF Available

Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration

Authors:
  • Simmons University

Abstract and Figures

Exposure to inescapable stressors increases both the rewarding properties and self-administration of cocaine through the signaling of the kappa-opioid receptor (KOR), but the effect of this signaling on other reinforcing agents remains unclear. The objective of this study is to test the hypothesis that signaling of the KOR mediates the forced swim stress (FSS)-induced potentiation of ethanol reward and self-administration. Male C57Bl/6J mice were tested in a biased ethanol-conditioned place preference (CPP) procedure, and both C57Bl/6J and prodynorphin gene-disrupted (Dyn -/-) mice were used in two-bottle free choice (TBC) assays, with or without exposure to FSS. To determine the role of the KOR in the resulting behaviors, the KOR agonist U50,488 (10 mg/kg) and antagonist nor-binaltorphimine (nor-BNI, 10 mg/kg) were administered prior to parallel testing. C57Bl/6J mice exposed to repeated FSS 5 min prior to daily place conditioning with ethanol (0.8 g/kg) demonstrated a 4.4-fold potentiation of ethanol-CPP compared to unstressed mice that was prevented by nor-BNI pretreatment. Likewise, pretreatment with U50,488 90 min prior to daily ethanol place conditioning resulted in a 2.8-fold potentiation of ethanol-CPP. In the TBC assay, exposure to FSS significantly increased the consumption of 10% (v/v) ethanol by 19.3% in a nor-BNI-sensitive manner. Notably, Dyn -/- mice consumed a similar volume of ethanol as wild-type littermates and C57Bl/6J mice, but did not demonstrate significant stress-induced increases in consumption. These data demonstrated a stress-induced potentiation of the rewarding effects and self-administration of ethanol mediated by KOR signaling.
Content may be subject to copyright.
ORIGINAL INVESTIGATION
Endogenous kappa-opioid mediation of stress-induced
potentiation of ethanol-conditioned place preference
and self-administration
Robin E. Sperling &Stacey M. Gomes &
Elizabeth I. Sypek &Amanda N. Carey &
Jay P. McLaughlin
Received: 28 October 2009 /Accepted: 22 March 2010
#Springer-Verlag 2010
Abstract
Rationale Exposure to inescapable stressors increases both
the rewarding properties and self-administration of cocaine
through the signaling of the kappa-opioid receptor (KOR),
but the effect of this signaling on other reinforcing agents
remains unclear.
Objective The objective of this study is to test the
hypothesis that signaling of the KOR mediates the forced
swim stress (FSS)-induced potentiation of ethanol reward
and self-administration.
Methods Male C57Bl/6J mice were tested in a biased
ethanol-conditioned place preference (CPP) procedure, and
both C57Bl/6J and prodynorphin gene-disrupted (Dyn /)
mice were used in two-bottle free choice (TBC) assays, with
or without exposure to FSS. To determine the role of the
KOR in the resulting behaviors, the KOR agonist U50,488
(10 mg/kg) and antagonist nor-binaltorphimine (nor-BNI,
10 mg/kg) were administered prior to parallel testing.
Results C57Bl/6J mice exposed to repeated FSS 5 min
prior to daily place conditioning with ethanol (0.8 g/kg)
demonstrated a 4.4-fold potentiation of ethanol-CPP com-
pared to unstressed mice that was prevented by nor-BNI
pretreatment. Likewise, pretreatment with U50,488 90 min
prior to daily ethanol place conditioning resulted in a 2.8-
fold potentiation of ethanol-CPP. In the TBC assay,
exposure to FSS significantly increased the consumption
of 10% (v/v) ethanol by 19.3% in a nor-BNI-sensitive
manner. Notably, Dyn /mice consumed a similar volume
of ethanol as wild-type littermates and C57Bl/6J mice, but
did not demonstrate significant stress-induced increases in
consumption.
Conclusions These data demonstrated a stress-induced po-
tentiation of the rewarding effects and self-administration of
ethanol mediated by KOR signaling.
Keywords Dynorphin .Kappa-opioid receptor .Stress .
Ethanol .Conditioned place preference .Self-administration
Introduction
Ethanol is a reinforcing agent, but its consumption is a
complex behavior influenced by multiple factors, including
genetic predisposition, social context, and exposure to
stress (Peele and Brodsky 2000;Koobetal.2004;
Vengeliene et al. 2008). In humans, stressful situations are
thought to increase alcohol intake (Pohorecky 1981), but
the effects of stress on ethanol consumption and reward are
less clear in animal studies. Acute exposure to social defeat
stress has been shown to suppress ethanol self-
administration in rats (van Erp and Miczek 2001; van Erp
et al. 2001; Funk et al. 2005), and acute isolation stress was
recently shown to suppress ethanol self-administration in
squirrel monkeys (McKenzie-Quirk and Miczek 2008). In
contrast, a number of studies have demonstrated increases
in ethanol consumption following chronic exposure to
either physical or psychological stressors in rodents (Mills
Robin E. Sperling and Stacey M. Gomes contributed equally to this
project.
R. E. Sperling :S. M. Gomes :E. I. Sypek :A. N. Carey :
J. P. McLaughlin
Department of Psychology, Northeastern University,
Boston, MA 02115, USA
S. M. Gomes :J. P. McLaughlin (*)
Torrey Pines Institute of Molecular Studies,
11350 SW Village Parkway,
Port St. Lucie, FL 34987, USA
e-mail: jmclaughlin@tpims.org
Psychopharmacology
DOI 10.1007/s00213-010-1844-5
et al. 1977; Wolffgramm 1990; Matsuzawa et al. 1998) and
primates (McKenzie-Quirk and Miczek 2008). Notably,
these latter results are consistent with animal studies
showing that exposure to inescapable stressors increased
[both the rewarding properties and self-administration of a
variety of drugs of abuse (Piazza et al. 1990;Shahamand
Stewart 1994;Willetal.1998). While many of these
effects have been attributed to signaling mediated by
corticosterone (Piazza et al. 1990; Shaham and Stewart
1994), recent studies are extending the neuropharmaco-
logical mechanisms by which stress may modulate drug
reward. For example, repeated exposure to stress was
shown to potentiate the rewarding effects of cocaine
through the prior activation of the endogenous kappa-
opioid system (McLaughlin et al. 2003,2006). However,
while implicated (Matsuzawa et al. 1999), the involvement
of endogenous kappa-opioid system activity in stress-
induced potentiation of ethanol reward has not been
closely examined.
A facilitating role for the kappa-opioid system in drug
reward is paradoxical, given that acute activation of kappa-
opioid receptors (KOR) has been shown to prevent the
rewarding effects induced by reinforcing drugs such as
cocaine and ethanol (Shippenberg and Herz 1986; Herz
1997; Shippenberg et al. 2007). Consistent with established
theory, acute KOR activation with the agonist (trans)-3,
4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]
benzeneacetamide (U50,488) decreased ethanol self-
administration in a two-bottle free choice assay (TBC;
Lindholm et al. 2001) and ethanol-conditioned place
preference (CPP; Logrip et al. 2009), and the KOR
antagonist nor-binaltorphimine (nor-BNI) significantly in-
creased ethanol consumption (Mitchell et al. 2005).
However, pretreatment with the KOR agonist CI-977
increased ethanol consumption over time in ethanol-
experienced but deprived rats (Hölter et al. 2000), and both
female prodynorphin gene-disrupted mice (Dyn /) and
male KOR gene-disrupted mice showed lower alcohol
consumption and preference (Blednov et al. 2006; Kovacs
et al. 2005a,b). Consistent with these last findings, U50,488
pretreatment was shown to increase cocaine self-
administration (Negus 2004) and mimic stress-induced
potentiation of cocaine-CPP (McLaughlin et al. 2006) when
the administration of cocaine is timed to coincide with the
observed termination of KOR agonist activity in a matching
antinociceptive assay. Overall, a growing set of evidence
suggests that KOR signaling may bidirectionally modulate
the reinforcing effects of drugs of abuse, including ethanol,
in a time-dependent manner that initially suppresses but
then potentiates ethanol reward.
This study hypothesized that the earlier stress-induced
activation of the endogenous kappa-opioid system would
mediate the later stress-induced potentiation of the reward-
ing effects and self-administration of ethanol. To test this,
C57Bl/6J mice were exposed repeatedly to forced swim
stress (FSS), and the rewarding effects of ethanol were
assessed using the CPP and TBC assays to examine
ethanol-seeking and consumption behaviors, respectively.
To determine the involvement of the endogenous kappa-
opioid system on stress-induced potentiation of ethanol
reward, Dyn /and wild-type mice were treated with
vehicle or nor-BNI (10 mg/kg, i.p.) prior to forced
swimming. Together, the results suggest that prior activa-
tion of the KOR may potentiate the rewarding effects of
ethanol.
Material and methods
Animals and housing Two hundred seven (153 for CPP, 54
for TBC) male C57Bl/6J mice (Jackson Labs, Bar Harbor,
Maine, USA), ten prodynorphin gene-disrupted (Dyn /)
mice, and nine wild-type littermates (Dyn +/+), 812 weeks
old and weighing 1929 g, were used in these experiments.
The C57Bl/6J mouse strain was selected for this work for
noted responses to stress (Lucki et al. 2001) and drugs of
abuse (Orsini et al. 2005), including a preference for
alcohol (Belknap et al. 1993; Risinger at al. 1998;Liet
al. 2005). They are also established subjects for the study of
the effects of stress on the response to reinforcing drugs
(McLaughlin et al. 2003,2006). Transgenic gene-disrupted
mice lacking the functional gene for prodynorphin were
provided by Dr. Ute Hochgeschwender (Oklahoma Medical
Research Foundation, Oklahoma City, OK, USA; see
Sharifi et al. 2001). Prodynorphin gene-disrupted mice
were backcrossed with C57Bl/6J mice for five generations,
resulting in a mixed strain background of 96.9% C57Bl/6J
and 3.1% 129sv. As such, responses of the prodynorphin
gene-disrupted mice were compared to wild-type littermates
of the same generation. The presence or absence of the
prodynorphin gene was confirmed in genomic DNA
isolated from tail tissue samples taken from each mouse
using polymerase chain reaction analysis as described
previously (Sharifi et al. 2001; McLaughlin et al. 2003).
All mice were housed by fours in self-standing plastic cages
(28 cm long×16 cm wide×13 cm high) within the vivarium
at Northeastern University or TPIMS unless otherwise
noted. Housing rooms were illuminated on a 12-h light/
dark cycle with lights on at 7:00 a.m. Note that testing of
mice was carried out during the light phase of the
photocycle, consistent with previous studies on the effects
of stress on drug-CPP responses (McLaughlin et al. 2003,
2006; Carey et al. 2007). Food pellets and water were
available ad libitum. All mice were housed and cared for in
accordance with the 1996 National Institute of Health
Guide for the Care and Use of Laboratory Animals and all
Psychopharmacology
procedures using mice were approved by the Northeastern
University and TPIMS Institutional Animal Care and Use
Committees.
Drugs Ethanol (95%, density= 0.816) was prepared in
solutions of 5%, 10%, or 20% (v/v) diluted in 0.9% saline
solution for CPP testing or diluted in water for the TBC
paradigm. U50,488 and nor-BNI were provided by the
NIDA Drug Supply. Nor-BNI was dissolved in a vehicle of
0.9% saline and administered once at a dose of 10 mg/kg,
i.p., 24 h prior to initial exposure to stress or testing.
U50,488 was dissolved in 0.9% saline and administered at a
dose of 10 mg/kg, i.p., daily, either 90 min prior to place
conditioning or 24 h prior to fluid measurement in the TBC
assay (see below) as noted.
Conditioned place preference One hundred fifty-three
C57Bl/6J mice were used in place-conditioning studies
using three-compartment boxes as described by Carey et al.
(2007). The Plexiglas compartment consisted of three
sections, two equal-sized outer sections (25×25×25 cm)
joined by a smaller central compartment (8.5×25 × 25 cm)
accessed by a sliding door (25×25 cm). The outer
compartments differed in wall striping (vertical vs horizon-
tal alternating black and white lines, 1.5 cm in width) and
floor texture (smooth vs rough). Mice were tested on day 1
before any treatment to establish initial preference for a
particular compartment. Testing involved placing individual
mice in the central compartment with the sliding doors
raised and allowing them to run freely between the two
outer compartments for 30 min. The apparatus itself is
balanced, with animals on average demonstrating an
equivalent amount of time in each of the three compart-
ments (588±11 s in the left compartment, 602±10 s in the
right compartment, and 609±12 s in the central compart-
ment) that did not statistically differ (one-way analysis of
variance (ANOVA), F
(2,456)
=0.95, p=0.39). For condition-
ing, the order of the ethanol administration was counter-
balanced across subjects (i.e., mice were randomly
separated into two groups, one group receiving saline in
the morning and ethanol in the afternoon and the other
group receiving ethanol in the morning and saline in the
afternoon (Houchi et al. 2005; see also Fig. 1a). Place-
conditioning sessions (saline or ethanol) were separated by
5 h, consistent with the time course of ethanol effects
(Faulkner et al. 1990). Note that order of place conditioning
was not found to significantly affect the final place
preference response at any dose of ethanol utilized
(comparing grouped post-conditioning preferences of the
0.4, 0.8, and 1.6 g/kg mice conditioned with saline first vs
those mice conditioned with ethanol first, F
(1,42)
=1.50,
p=0.23; one-way ANOVA). A biased ethanol place-
conditioning design was then utilized, as it produces
ethanol-CPP in C57Bl/6 mice (Nocjar et al. 1999;
Middaugh and Bandy 2000; Gremel et al. 2006). As
adapted for use here, on days 25 mice were administered
10 ml/kg, i.p., of an ethanol solution (5%, 10%, or 20%
(v/v), corresponding to 0.4, 0.8, and 1.6 g/kg ethanol;
Kuzman et al. 2003; Thanos et al. 2005) once daily and
immediately confined in their initially non-preferred side
for 25 min. For alternating place-conditioning sessions
(a.m. or p.m.), mice were administered an equivalent
volume of saline and immediately placed in their initially
preferred side for 25 min. On day 6, testing of place-
conditioned preference was conducted when mice ran freely
through the conditioning apparatus for 30 min. Time spent
in each compartment was measured and compared to the
initial preference.
Alcohol preference test: two-bottle free choice ATBC
paradigm with escalating ethanol concentrations was used
(Thiele et al. 1998; Li et al. 2005; Gabriel and Cunningham
2008) to examine ethanol preference. Mice (54 C57Bl/6J,
Day: 1 6 5 4 3 2
-or- -or- -or- -or-
Preference test, 30 min
Ethanol (0.4, 0.8 or 1.6 g/kg) place conditioning, 25 min
Saline place conditioning, 25 min
b
a
Fig. 1 Ethanol-conditioned place preference (CPP) is dose-
dependent. aUpper schematic: experimental design for ethanol-CPP
testing. After an initial 30-min determination of place preference
(triangle, day 1), mice were place conditioned in the non-preferred
chamber for the next 4 days with ethanol (squares; 0.4, 0.8, or
1.6 g/kg) either 5 h before or after saline place conditioning (0.9%,
circles) in the opposite chamber. Final CPP was determined on day 6.
bAll 44 mice demonstrated similar preconditioning place preferences
(Pre-CPP,white bar), which were thus grouped together here. Mice
place conditioned for 4 days with 0.4 g/kg ethanol (gray bar) did not
demonstrate a change from the initial place preference response. In
contrast, place conditioning with 0.8 (black bar) or 1.6 g/kg (gray
thatched bar) ethanol produced a significant preference for the
ethanol-paired environment. Asterisk,p<0.05 from preconditioning
response; analysis of variance+Tukey
Psychopharmacology
ten Dyn /, and nine Dyn +/+ littermates) were housed
individually and habituated for 5 days to drink from two
bottles (148 mL) containing sterile water. After habituation,
mice were given 24 h access to two bottles, one containing
tap water and the other containing an ethanol solution. Each
bottle was filled with 100 mL of fluid replaced after every
measurement. The concentration of ethanol (v/v)was
increased every 4 days with mice receiving 3%, 6%, and
finally 10% ethanol over the course of the experiment. To
control for position preference, the position of the bottles
was changed every 24 h (at 1200 hours; Li et al. 2005;
Mitchell et al. 2005). Fluid intake was measured to the
closest milliliter every 2 days (Thiele et al. 1998) or every
day after experimental manipulation. To measure ethanol
preference, ethanol-preference ratios were calculated for
each concentration by dividing the volume of ethanol
solution consumed by the total volume of liquid (ethanol
plus water) consumed for each day (Thiele et al. 1998;
Lindholm et al. 2001). To control for leakage and
evaporation, an empty cage containing one bottle of tap
water and one bottle of ethanol solution was placed
alongside experimental cages. Body weights were mea-
sured at the beginning of each change in ethanol concen-
tration and at the end of the experiment. Unfortunately,
daily weights were not consistently collected for all
animals, precluding a complete set of calculations, but the
C57Bl/6J mice consumed an increasing amount of ethanol
correlated with the solution of ethanol available (3%=4.3 ±
0.31 g/kg/day, 6%=7.7±0.56 g/kg/day, and 10%=11.8±
0.96 g/kg/day at the end of each 4-day training period).
Forced swim stress To measure the effect of FSS on
ethanol reward and consumption, mice were exposed to a
forced swim test, as detailed by McLaughlin et al. (2003)
and as modified below. The FSS paradigm utilized was a
2-day (for TBC) or 4-day (for CPP) procedure in which
mice repeatedly swam without the opportunity to escape.
Mice were treated with vehicle or nor-BNI (10 mg/kg, i.p.)
24 h prior to initial FSS exposure. In all swim trials,
animals were placed in an opaque 5-L cylinder filled with
4 L of 3032°C water. On day 1 (CPP day 1, or TBC day
17), forced swimming occurred over a single 15-min trial
(Fig. 2a). On day 2 (CPP day 2, or TBC day 18), mice
were exposed to four 6-min trials of forced swimming.
Onday3(CPPday3)animalsagainswaminasingle
15-min trial, but on day 4 (CPP day 4), mice were
exposed to three 6-min trials. Upon completion of each
trial, all mice were removed from the water, towel-
dried, and returned to their home cages for approxi-
mately 6 min. Note that when each day's exposure to all
FSS trials was finished, mice subject to CPP testing were
administered ethanol and place conditioned approximately
5 min later as described above.
To measure the effect of FSS on ethanol self-
administration, mice were exposed to a modified FSS as
stated above. Mice were conditioned to 10% ethanol for
4 days and then either treated with vehicle (ten C57Bl/6J; all
Dyn +/+ and /mice) or nor-BNI (10 mg/kg i.p.; nine
C57Bl/6J mice). Two hours later, mice were exposed to FSS
over the next 2 days. On the first day of stress (day 17 of the
TBC protocol), mice were exposed to a single 15-min FSS
and then returned to their TBC cage. On day 18, mice were
again exposed to FSS over four 6-min trials before immediate
return to their two-bottle cage.
Day: 1 6 5 4 3 2
-or- -or- -or- -or-
Preference test, 30 min
Ethanol (0.8 g/kg) place conditioning, 25 min
Saline place conditioning, 25 min
vehicle or nor-BNI (10 mg/kg, i.p.)
Forced swim stress
b
a
Fig. 2 Exposure to stress results in a kappa-opioid receptor-mediated
potentiation of ethanol-conditioned place preference (CPP). aUpper
schematic: experimental design for ethanol-CPP testing. After an
initial 30-min determination of place preference (triangle, day 1), mice
were pretreated on day 1 (arrow) with either vehicle (0.9% saline) or
nor-binaltorphimine (BNI; 10 mg/kg, i.p.). On days 25, mice were
then left in home cages or exposed to forced swim stress (FSS, gray
diamonds) and place conditioned daily with 1.6 g/kg ethanol (squares)
either 5 h before or after saline place conditioning (circles) in the
opposite chamber. Final CPP was determined on day 6 (triangle). b
Unstressed mice demonstrated ethanol-CPP after place conditioning
(black bar). Mice administered vehicle before repeated exposure to
forced swim stress demonstrated significant potentiation of ethanol-
CPP when place conditioned 5 min after exposure to FSS (gray bar).
Pretreatment of mice with nor-BNI (striped gray bar)prevented
stress-induced potentiation of ethanol-CPP responses. Notably, nor-
BNI pretreatment alone did not alter ethanol-CPP (thatched dark
gray bar). Asterisk,p<0.05 from preconditioning response; dagger,
p<0.05 from ethanol-CPP of unstressed mice; double dagger,p<
0.05 from ethanol-CPP response of FSS-exposed mice; analysis of
variance+Tukey
Psychopharmacology
Antinociceptive testing using the 55°C warm-water tail-
withdrawal assay The 55°C warm-water tail-withdrawal
assay was used as described previously (McLaughlin et al.
2003), with the latency of the mouse to withdraw its tail
taken as an endpoint. Tail-withdrawal latencies were collect-
ed before and every 10 min after U50,488 (10 mg/kg i.p.)
exposure until the latency to remove the tail returned to
baseline (pre-drug) responses. A cutoff time of 15 s was used
to prevent tissue damage. Note that from this data (see
Results), a 90-min pretreatment time with this dose of
U50,488 was used in the CPP (24 mice) and TBC (eight
mice alone and nine mice with nor-BNI pretreatment) assays,
as the waxing and waning time course of antinociceptive
activity indicates the onset and termination of agonist-
induced KOR signaling.
Statistical analysis Antinociception was analyzed by com-
paring pre- and post-U50,488 tail-withdrawal latencies
using paired-samples ttests to test for significant increases
in latency after drug administration. All other results were
compared and analyzed using one-way and two-way
ANOVA as appropriate using the SPSS 14.0 statistical
package (Chicago, IL, USA). Analyses examined the main
effect of CPP phase (e.g., pre- or post-place conditioning)
by dose (0.4, 0.8, 1.6 g/kg) or ethanol consumption by
training solution (0%, 3%, 6%, or 10%) or day (day 17, and
then post-treatment on days 18 and 19) and the interaction
of environmental condition (unstressed or stress-exposed),
genotype (C57Bl/6J or prodynorphin gene-disrupted or
wild-type mice), and drug pretreatment (U50,488, nor-
BNI or vehicle). Significant effects were further analyzed
with Tukey honestly significant difference (HSD) post hoc
testing. Data are presented as mean difference in time spent
on the drug-paired side (seconds), ethanol consumed
(milliliters), or ethanol-preference ratio ± SEM of the animal
treatment group, with significance set at p<0.05.
Results
Optimization of dose in ethanol-conditioned place
preference testing with C57Bl/6J mice
Optimization of ethanol place conditioning was conducted
with ethanol doses of 0.4, 0.8, or 1.6 g/kg once daily for
4 days (Fig. 1a). Results indicated a significant main effect
of ethanol dose (F
(3,87)
=17.5, p<0.001; one-way ANOVA).
Mice place conditioned with 0.4 g/kg ethanol displayed no
significant change in preference from the initially preferred
chamber to the ethanol-paired chamber (Fig. 1b). However,
mice place conditioned 25 min daily with 0.8 or 1.6 g/kg
doses of ethanol spent significantly more time in the
ethanol-paired chamber in final preference testing (p<
0.01, Tukey HSD test; Fig. 1b). Although not significantly
different from the effect of place conditioning with a
1.6-g/kg dose of ethanol, a peak effect was observed with
0.8 g/kg ethanol (132±65.5 s), prompting use of the
0.8-g/kg dose of ethanol in CPP testing for the remainder
of the study.
Stress-induced potentiation of ethanol-conditioned place
preference is mediated by signaling of the kappa-opioid
receptor
The effect of FSS exposure on ethanol-CPP was evaluated.
After obtaining preconditioning responses in the CPP
apparatus for subsequent comparisons, C57Bl/6J mice were
administered vehicle or the KOR antagonist nor-BNI
(10 mg/kg; Fig. 2a). On each of the following 4 days, mice
were left idle in home cages or exposed to FSS daily prior
to ethanol place conditioning. Conditioning with ethanol
produced significant place preference across all conditions
tested (F
(4,137)
=27.7, p<0.0001; one-way ANOVA). Mice
pretreated with vehicle and exposed to daily FSS before
ethanol place conditioning demonstrated a significant
4.4-fold potentiation of ethanol-CPP over the response of
unstressed mice (p<0.01, Tukey HSD test; Fig. 2b).
Pretreatment with nor-BNI prevented the FSS-induced
potentiation of ethanol-CPP, with a response significantly
less than the vehicle-treated, FSS-exposed mice (p< 0.01,
Tukey HSD test), but not different from the response of
unstressed mice (Fig. 2b). Importantly, nor-BNI pretreat-
ment in the absence of FSS exposure did not significantly
affect the place conditioning response to ethanol (p=0.88,
n.s.; Fig. 2b). Moreover, nor-BNI pretreatment alone did
not induce CPP under these conditions, as ten mice
pretreated separately with nor-BNI (10 mg/kg, i.p.) prior
to vehicle place conditioning (i.e., without ethanol) did not
demonstrate a significant change in place preference from
initial preconditioning responses (141.5 ± 65.9 s precondi-
tioning preference as compared to 176.4±46.6 s post-
CPP; p=0.61, Student's ttest.)
Prolonged prior U50,488-induced activation of KOR
potentiates ethanol-CPP
While acute activation of the KOR prevents cocaine-
(McLaughlin et al. 2006) and ethanol-CPP (Logrip et al.
2009), previous work has shown that prolonged prior
activation of KOR paradoxically potentiated CPP responses
(McLaughlin et al. 2006). To determine if a similar
prolonged prior KOR activation might mimic the effects
of FSS exposure sufficiently to potentiate ethanol-CPP,
mice were administered the KOR agonist U50,488
(10 mg/kg, i.p.) daily 90 min prior to ethanol place
conditioning (Fig. 3a). This duration of pretreatment was
Psychopharmacology
chosen as U50,488-induced antinociception at this dose
was shown to recover at this time point when measured
with the 55°C warm-water tail-withdrawal assay, suggest-
ing the termination of initial agonist activity. Administra-
tion of U50,488 increased the tail-withdrawal latency from
baseline (1.59 ± 0.16 s) to a peak value 40 min after
administration (12.1±1.76 s; p<0.001), returning to laten-
cies similar to baseline responses after 90 min (2.09±0.3 s;
p=0.32). Much like a previous demonstration of KOR
agonist-induced potentiation of cocaine-CPP (McLaughlin
et al. 2006), prior treatment with U50,488 90 min before
ethanol significantly potentiated the resulting CPP com-
pared with vehicle-pretreated mice (F
(3,124)
=30.7, p<
0.0001; one-way ANOVA, followed by Tukey HSD post
hoc test; Fig. 3b). Moreover, the potentiation produced by
prior U50,488-mediated stimulation was itself prevented by
KOR antagonist pretreatment, as mice administered nor-BNI
before daily U50,488 (Fig. 3a) subsequently demonstrated a
normal ethanol-CPP response that was significantly less than
theresponseofU50,488-pretreatedmice(p<0.01; Fig. 3b),
but not significantly different from the ethanol-CPP response
of vehicle-treated, unstressed mice.
Characterization of ethanol consumption in C57Bl/6J
or prodynorphin (+/+) or (/) mice using the two-bottle
free choice (TBC) assay
Average consumption of solutions containing ethanol by
C57Bl/6J, prodynorphin gene-disrupted (Dyn /)and
wild-type littermate (Dyn +/+) mice was examined with
the TBC assay. Amount of ethanol consumed and the
percentage of ethanol over total fluid consumption were
analyzed at the end of each training period with water (day
5), 3% (day 9), 6% (day 13), or 10% ethanol (day 17)
solutions (Fig. 4). The volume of ethanol consumed at the
end of each training period did not change significantly
across dose or strain (F
(6,279)
=0.84, p=0.54; two-way
ANOVA; Fig. 4a). When consumption of solutions was
analyzed as a percentage of ethanol consumed out of total
fluid intake, no significant differences were observed
among the mouse strains after 4 days' training with each
solution (F
(6,279)
=1.31, p=0.25; two-way ANOVA;
Fig. 4b).
Prior exposure to FSS or a KOR agonist potentiates ethanol
consumption in the TBC assay
Following the measurements completing ethanol-
preference training, C57Bl/6J mice were pretreated with
vehicle (0.9% saline) or nor-BNI (10 mg/kg, i.p.). Two
hours later, half of each group were exposed to FSS and
returned to their two-bottle cages. After 24 h, the amount
of ethanol consumed was measured. Exposure to FSS
significantly increased the percentage of ethanol consumed
over this period (F
(4,84)
=2.61, p<0.05; one-way ANOVA;
Fig. 5). Consistent with the CPP results, nor-BNI
pretreatment prevented the FSS-induced potentiation (p<
0.05; Fig. 5). Importantly, nor-BNI pretreatment did not
significantly alter the amount or percentage of total
ethanol consumed over this time period by ethanol-
trained, unstressed mice (6.1± 1.2 ml of 10% ethanol
consumed over the matching 24-h period, for a percentage
of 50.5±6.1 ethanol of total fluid intake; p=0.07, n.s.).
An additional set of TBC-trained mice was administered
U50,488 (10 mg/kg, i.p.) and returned to their two-bottle
cages for a measurement of 10% ethanol consumed 24 h
later. Consistent with the CPP testing, mice pretreated with
Day: 1 6 5 4 3 2
-or- -or- -or- -or-
Preference test, 30 min
Ethanol (0.8 g/kg) place conditioning, 25 min
Saline place conditioning, 25 min
vehicle or nor-BNI (10 mg/kg, i.p.)
U50,488 (10 mg/kg, i.p., -90 min prior to EtOH)
b
a
Fig. 3 Prolonged exposure to kappa-opioid receptor (KOR) agonist
results in potentiation of ethanol-conditioned place preference (CPP).
aUpper schematic: experimental design for ethanol-CPP testing.
After an initial 30-min determination of place preference (triangle,
day 1), mice were pretreated (arrow) with either vehicle or nor-
binaltorphimine (BNI; 10 mg/kg, i.p.) and injected with KOR agonist
U50,488 (10 mg/kg, i.p.; gray diamond) prior to place conditioning
with 0.8 g/kg ethanol (squares) either 5 h before or after saline place
conditioning (circles, 0.9%, i.p.) in the opposite chamber for the next
4 days. Final CPP was determined on day 6. bMice demonstrated
ethanol-CPP after place conditioning (black bar). Mice pretreated
daily with U50,488 90 min prior to place conditioning with 0.8 g/kg
ethanol demonstrated potentiation of ethanol-CPP (gray bar). Pre-
treatment with nor-BNI prior to U50,488 treatment (striped gray bar)
prevented the agonist-induced potentiation of ethanol-CPP. Asterisk,p
<0.05 from preconditioning response; dagger,p<0.05 from ethanol-
CPP of unstressed mice; double dagger,p<0.05 from ethanol-CPP
response of forced swim stress-exposed mice; analysis of variance +
Tukey
Psychopharmacology
U50,488 consumed a significantly greater percentage of
ethanol than unstressed, vehicle-treated mice (F
(3,77)
=4.54,
p<0.01; one-way ANOVA; Fig. 5). Notably, the percentage
of ethanol consumed was equivalent to the percentage
consumed after a single exposure to FSS (p=0.64, n.s.),
suggesting that prior agonist-induced stimulation of the
KOR was sufficient to increase the percentage of ethanol
consumed.
Interestingly, the effects of both FSS and KOR agonist
stimulation on the percentage of ethanol consumed were
not found to be long lasting. When mice were exposed for
an additional day to FSS or a second administration of
U50,488, no significant differences in ethanol consumption
were observed among all groups tested (F
(4,80)
=0.87, p<
0.05; one-way ANOVA; Fig. 5, rightmost symbols).
Prodynorphin gene-disrupted mice do not demonstrate FSS-
induced potentiation of ethanol consumption in the two-
bottle choice assay
The possible involvement of the endogenous KOR system in
the stress-induced potentiation of ethanol consumption was
assessed using Dyn /mice and their wild-type littermates.
Wild-type littermates exposed to FSS demonstrated a signif-
icant increase (to 65.6± 6.0) in the percentage of ethanol
consumed as compared to vehicle-treated, unstressed C57Bl/
6J mice (F
(4,87)
=5.78, p<0.05; one-way ANOVA; Fig. 6).
This effect was statistically equivalent to the FSS-induced
potentiation demonstrated by C57Bl/6J mice (p=0.24, n.s.),
but significantly different from the percentage of ethanol
consumed by Dyn /mice exposed to FSS (44.5±5.5%; p
<0.01, Tukey HSD test; Fig. 6), which was not significantly
different from the percentage of ethanol consumed by the
unstressed C57Bl/6J mice (p=0.34).
Notably, the capacity for FSS-induced potentiation of
ethanol consumption was again demonstrated to be brief.
Exposure to an additional day of FSS did not significantly
change the percentage of ethanol consumed across the
groups tested (F
(4.83)
=0.51, p=0.73; one-way ANOVA;
Fig. 6, rightmost points).
Fig. 5 Prior exposure to forced swim stress (FSS) or kappa-opioid
receptor agonist potentiates ethanol consumption in the two-bottle
choice assay. Unstressed mice (circles) were administered vehicle,
while other mice were exposed to forced swim stress (white
diamonds) or treatment with U50,488 (squares)24hpriorto
collection of ethanol consumed. FSS-induced potentiation of 10%
ethanol consumption was blocked by nor-binaltorphimine pretreat-
ment (gray diamonds). Asterisk,p<0.05 from vehicle-treated, un-
stressed mice; dagger,p<0.05 from FSS-exposed mice; two-way
analysis of variance+Tukey
Fig. 4 Ethanol consumption in the two-bottle free choice assay is
consistent among strains and across concentrations of ethanol tested.
Data is shown for fluid intake on last day of training with each
solution, be it water (day 5), 3% ethanol (day 9), 6% ethanol (day 13),
or 10% v/vethanol (day 17). aVolume consumption of ethanol (in
milliliters per day) is consistent on the last day of training with each
solution throughout 17-day training among C57Bl/6J (circles),
prodynorphin wild-type (Dyn +/+, squares), and prodynorphin gene-
disrupted (Dyn /,triangles) mice. bPercentage of ethanol
consumed in total fluid intake over 24 h is also consistent throughout
17-day training across C57Bl/6J (circles), prodynorphin wild-type
(Dyn +/+, squares), and prodynorphin gene-disrupted (Dyn /,
triangles) mice
Psychopharmacology
Discussion
The principal finding of this study was that repeated
exposure to FSS potentiated ethanol-CPP observed in a
biased procedure. Stress-induced potentiation of ethanol-
CPP was blocked by pretreatment with the KOR antagonist
nor-BNI and mimicked by prior administration of the KOR
agonist U50,488. Exposure to stress also significantly
increased the amount and percentage (of total fluid intake)
of ethanol consumed in a TBC assay, effects again
mimicked by prior exposure to U50,488. These effects
were blocked by nor-BNI pretreatment or prodynorphin
gene disruption.
The demonstration of ethanol-CPP in male C57Bl/6J
mice is perhaps surprising given the failure of these mice to
demonstrate place preference for ethanol in counterbal-
anced place-conditioning designs (Cunningham et al.
1992). However, the present data is consistent with
demonstrations of the successful use of the biased place-
conditioning design (i.e., place-conditioning subjects with
ethanol in the initially non-preferred chamber) to produce
ethanol-CPP with C57Bl/6 mice (Kelley et al. 1997; Nocjar
et al. 1999; Middaugh and Bandy 2000). In fact, the
ethanol-CPP demonstrated by C57Bl/6J mice after place
conditioning in a biased apparatus and subject assignment
procedure was thought to possibly suggest a greater ability
to detect a smaller rewarding effect in the biased apparatus
in a recent study (Gremel et al. 2006).
While certain types and exposures to stress have been
noted to acutely suppress ethanol self-administration (van
Erp and Miczek 2001; van Erp et al. 2001; Funk et al.
2005), stress-induced increases in the rewarding effects of
ethanol are also well established in animal models. Rats
exposed to electric foot shock (Mills et al. 1977),
immobilization stress (Rockman et al. 1987), and isolation
stress/psychological stress (Wolffgramm 1990) all demon-
strate increased consumption of ethanol during periods
corresponding with the recovery from stress. Consistent
with this, the present results suggest the activity of the
endogenous kappa-opioid system mediated the stress-
induced potentiation of the rewarding effects and self-
administration of ethanol. Dynorphin, the endogenous
ligand for the KOR, is known to be released in C57Bl/6J
brain in response to exposure to FSS (Shirayama et al.
2004). Since a 24-h pretreatment with nor-BNI prevented
the potentiation of ethanol reward and consumption, it is
plausible that a stress-induced release of dynorphin peptides
activated KOR signaling to paradoxically potentiate ethanol
reward. While not directly tested in the present study, KOR
gene-disrupted mice previously exposed to stress did not
demonstrate increases in cocaine-CPP (McLaughlin et al.
2006). Additional mice in that report pretreated with
U50,488 and place conditioned immediately after the
cessation of the antinociceptive effects of the KOR agonist
mimicked the effect of stress, demonstrating a potentiation
of cocaine-CPP (McLaughlin et al. 2006). Likewise, prior
exposure to U50,488 here also mimicked the effect of
stress, potentiating the rewarding effects of ethanol as well
as the percentage of ethanol consumed. This result is
consistent with a previous report in which chronic
administration of the KOR agonist CI-977 potentiated
ethanol intake and preference in relapse-like drinking
measured in alcohol-deprived, but long-term ethanol-
experienced, rats (Hölter et al. 2000). Earlier work has also
demonstrated that exposure to conditioned fear stress
potentiated ethanol-CPP (Matsuzawa et al. 1998,1999).
The authors concluded that KOR may modulate the
rewarding effect of ethanol under this psychological stress,
but nor-BNI pretreatment prior to ethanol conditioning (but
after exposure to foot shock) slightly increased the
potentiation of ethanol-CPP. It is possible that procedural
differences may account for the contradiction between
studies. In the present study, nor-BNI was administered
prior to FSS exposure, since previous work has shown
KOR antagonists administered after exposure to stress are
ineffective in preventing stress-induced changes in mea-
sured behavior (Carey et al. 2009; Aldrich et al. 2009).
The varied responses to stress by an organism suggest
alternative mechanisms may underlie the potentiation of
Fig. 6 Prodynorphin gene-disrupted mice do not demonstrate forced
swim stress (FSS)-induced potentiation of ethanol consumption in the
two-bottle free choice (TBC) assay. After completion of training on
day 17 of the TBC protocol, C57Bl/6J (circles), prodynorphin gene-
deleted (Dyn /,triangles), and wild-type (Dyn +/+, squares) mice
were administered vehicle. Dyn /and Dyn +/+ mice were exposed
to FSS (arrows) on both days 17 and 18 and ethanol consumption
measured 24 h after each exposure. Asterisk,p<0.05 from unstressed
C57Bl/6J; dagger,p<0.05 from stress-exposed Dyn +/+; analysis of
variance+ Tukey
Psychopharmacology
ethanol-CPP and consumption observed here, such as the
possible effect of corticosterone (Lê et al. 2000). However,
previous studies have shown that the FSS-induced release
of corticosterone is not affected by nor-BNI pretreatment or
prodynorphin gene disruption (McLaughlin et al. 2006). As
such, it seems unlikely that the prevented potentiation of
ethanol-CPP observed here is due to a disruption of
hypothalamicpituitaryadrenal axis function, but instead
that a disruption of the kappa system alone might suffice.
Alternatively, the mediation of ethanol reward and con-
sumption by the endogenous mu- and delta-opioid systems
raises the possibility that the present results were due to
interactions at other opioid receptors than KOR. Activation
of delta- and mu-opioid receptors has been implicated in
reward mechanisms and behavioral reinforcement of etha-
nol (Vengeliene et al. 2008), and blockade of these
receptors (Stromberg et al. 1998) or mu-opioid receptor
gene disruption (Roberts et al. 2000) has been shown to
decrease ethanol self-administration. However, this alterna-
tive seems unlikely in the present study, given the
established selectivity of nor-BNI for the KOR at the dose
and duration of pretreatment used (McLaughlin et al. 2003)
and the use of prodynorphin gene-disrupted animals in the
present study, although additional testing with KOR gene-
disrupted mice or additional KOR-selective antagonists
would be of value.
It is conceivable that the potentiation of ethanol reward
demonstrated by the FSS- or U50,488-exposed mice may
result from a stress- and KOR-induced enhancement of
learning and memory performance. KOR agonists have
been demonstrated to improve performance in learning and
memory tasks (Hiramatsu and Hoshino 2005; Kuzmin et al.
2006). However, this seems unlikely given that the memory
performance enhancements have been attributed to agonist
activity through non-opioid sites (Hiramatsu and Hoshino
2005; Kuzmin et al. 2006), and a recent study suggests that
KOR signaling seems to impair novel object recognition,
another animal model of learning and memory (Carey et al.
2009).
In a more plausible alternative, the stress-induced increase
in ethanol-seeking behavior observed here might be attributed
to attempts to counteract symptoms of anxiety. Presentation of
anxiety-like behaviors is predictive of ethanol self-
administration in rats (Spanagel et al. 1995), squirrel monkeys
(McKenzie-Quirk and Miczek 2008), and humans (Willinger
et al. 2002), and ethanol was shown to produce anxiolytic
effects similar to diazepam in rat models of anxiety (Wilson
et al. 2004). KOR antagonists were recently shown to have
anxiolytic effects (Knoll et al. 2007), suggesting that the nor-
BNI used here may have prevented stress-induced potenti-
ation of ethanol effects by reducing anxiety directly, but
further parallel testing in mouse models of anxiety will be
needed to investigate this alternative.
Of interest, the potentiating effects of stress- or U50,488-
exposure on the percentage of ethanol consumed in the
TBC assay were shown to be of short duration, lasting no
more than 1 day. These effects suggest either a brief impact
by stress on reward circuitry, or a possible habituation to
predictable stress. This relatively short duration of action is
of interest, given reports of lengthy stress-induced increases
in ethanol consumption in BALB/cJ mice (Lowery et al.
2008), and worthy of further examination. Use of a set of
chronic unpredictable stressors might conceivably extend
stress-induced potentiation for a longer duration, although
further testing and characterization of the duration of stress-
induced vulnerability to increased ethanol consumption are
needed.
The potentiation of the rewarding effects of ethanol by
the kappa-opioid system seems paradoxical, as acute
administration of kappa agonists along with ethanol are
known to block ethanol-CPP (Matsuzawa et al. 1999;
Logrip et al. 2009) and voluntary ethanol intake (Lindholm
et al. 2001). In addition, kappa-opioid agonists produce
conditioned place aversion in rodents (Shippenberg and
Herz 1986; Suzuki et al 1992; Matsuzawa et al. 1999).
However, these studies with KOR agonists utilized the
acute administration and activity of KOR agonists, whereas
the present study examined the effect of a prior activation
of the KOR with chronic KOR agonist stimulation, which
reports suggest may potentiate drug reward (Hölter et al.
2000; Negus 2004; McLaughlin et al. 2006). Given a recent
report where nor-BNI was found to attenuate ethanol self-
administration in rats previously made dependent on
ethanol, but had no effect on nondependent animals
(Walker and Koob 2008), it could be hypothesized that
repeated exposure to stress or KOR agonists produces a
dysphoric state which subsequently enhances the rewarding
value of euphoric agents that attenuate this effect
(McLaughlin et al. 2006; Walker and Koob 2008).
Alternatively, a direct neurobiological mechanism may
account for the potentiation of drug reward (Sommer et
al. 2006; Zapata and Shippenberg 2006), although neither
theory was directly tested in the present study.
Importantly, nor-BNI inhibition of KOR or KOR gene
disruption increased the ethanol-induced release of dopa-
mine in the mouse nucleus accumbens (Zapata and
Shippenberg 2006), and a single administration of nor-
BNI was reported to increase ethanol consumption, but not
CPP, in long-term ethanol-experienced rats (Mitchell et al.
2005). This finding contradicts the present results, where
nor-BNI did not significantly alter ethanol reward in
unstressed mice, although this is consistent with other
reports (Hölter et al. 2000; Lindholm et al. 2001).
Interestingly, KOR gene-disrupted mice (Kovacs et al.
2005) and female prodynorphin gene-disrupted mice
(Blednov et al. 2006) have exhibited lower rates of ethanol
Psychopharmacology
self-administration than wild-type littermates. Curiously,
male Dyn /mice demonstrate no change in ethanol
consumption (Blednov et al. 2006), a finding confirmed
with the present data. It is notable that the effects of stress
on ethanol reward or consumption were not investigated in
these mouse studies, and may suggest an important
procedural difference in these results. Overall, despite
contradictions, these results suggest the significance of the
endogenous kappa-opioid system in the maintenance of
ethanol consumption and suggest a bidirectional regulation
of ethanol reward by the KOR system that requires further
investigation.
In summary, these data demonstrated a stress-induced
potentiation of the rewarding effects and self-administration
of ethanol mediated by prior activation of KOR signaling
and suggest that KOR antagonists may prove beneficial in
preventing stress-induced increases in ethanol consumption.
Acknowledgements We thank Dr. Ute Hochgeschwender for gen-
erously providing the prodynorphin gene-disrupted mice. This
research is supported by R03 DA16415 from the National Institute
on Drug Abuse to JPM and funds from the State of Florida, Executive
Office of the Governor's Office of Tourism, Trade, and Economic
Development. Mice were housed and cared for in the Northeastern
University or TPIMS animal facilities in accordance with the 1996
National Institutes of Health Guide for the Care and Use of
Laboratory Animals. All studies were performed after prior approval
by the local Institutional Animal Care and Use Committee and are in
full compliance with the current laws of the USA.
Conflicts of interest The authors declare that they have full control
of all primary data. Except for income received from our primary
employers, no financial support or compensation has been received
from any individual or corporate entity over the past 3 years for
research or professional services related to this project, and there are
no personal financial holdings that could be perceived as constituting
a potential conflict of interest.
References
Aldrich JV, Patkar KA, McLaughlin JP (2009) Zyklophin, a
systemically active selective kappa opioid receptor peptide
antagonist with short duration of action. Proc Natl Acad Sci
USA 106:1839618401
Belknap JK, Crabbe JC, Young ER (1993) Voluntary consumption of
ethanol in 15 inbred mouse strains. Psychopharmacology
112:503510
Blednov YA, Walker D, Martinez M, Harris RA (2006) Reduced
alcohol consumption in mice lacking preprodynorphin. Alcohol
40:7386
Carey AN, Borozny K, Aldrich JV, McLaughlin JP (2007) Reinstatement
of cocaine place-conditioning prevented by the peptide kappa-
opioid receptor antagonist arodyn. Eur J Pharmacol 569:8489
Carey AN, Lyons AM, Shay CF, Dunton O, McLaughlin JP (2009)
Endogenous κopioid activation mediates stress-induced deficits
in learning and memory. J Neurosci 29:42934300
Cunningham CL, Neihus DR, Malott DH, Prather LK (1992) Genetic
differences in the rewarding and activating effects of morphine
and ethanol. Psychopharmacology (Berlin) 107:385393
Faulkner TP, Cantleberry SB, Watts VJ, Hussain AS (1990)
Comparative pharmacokinetics of ethanol in inbred strains of
mice using doses based on total body water. Alcohol Clin Exp
Res 14:8286
Funk D, Harding S, Juzytsch W, AD (2005) Effects of
unconditioned and conditioned social defeat on alcohol self-
administration and reinstatement of alcohol seeking in rats.
Psychopharmacologia 183:341349
Gabriel KI, Cunningham CL (2008) Effects of maternal strain on
ethanol responses in reciprocal F1 C57BL/6J and DBA/2J hybrid
mice. Genes Brain Behav 7:276287
Gremel CM, Gabriel KI, Cunningham CL (2006) Topiramate does not
affect the acquisition or expression of ethanol conditioned place
preference in DBA/2J or C57BL/6J mice. Alcohol Clin Exp Res
30:783790
Herz A (1997) Endogenous opioid systems and alcohol addiction.
Psychopharmacology 129:99111
Hiramatsu M, Hoshino T (2005) Improvement of memory impairment
by (+)- and ()-pentazocine via sigma, but not kappa opioid
receptors. Brain Res 1057:7280
Hölter SM, Henniger MSH, Lipkowski AW, Spanagel R (2000)
Kappa-opioid receptors and relapse-like drinking in long-term
ethanol-experienced rats. Psychopharmacology 153:93102
HouchiH,BabovicD,PierreficheO,LedentC,DaoustM,Naassila
M (2005) CB1 receptor knockout mice display reduced
ethanol-induced conditioned place preference and increased
striatal dopamine D2 receptors. Neuropsychopharmacology
30:339349
Kelley BM, Bandy A-LE, Middaugh LD (1997) A study examining
intravenous ethanol-conditioned place preference in C57BL/6J
mice. Alcohol Clin Exp Res 21:16611666
Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA Jr (2007)
Anxiolytic-like effects of kappa-opioid receptor antagonists in
models of unlearned and learned fear in rats. J Pharmacol Exp
Ther 323:838845
Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A,
O'Dell LE, Parsons LH, Sanna PP (2004) Neurobiological
mechanisms in the transition from drug use to drug dependence.
Neurosci Biobehav Rev 27:739749
Kovacs KM, Szakall I, O'Brien D, Wang R, Vinod KY, Saito M,
Simonin F, Kieffer BL, Vadasz C (2005) Decreased oral self-
administration of alcohol in κ-opioid receptor knock-out mice.
Alcohol Clin Exp Res 29:730738
Kuzman A, Sandin J, Terenius L, Ögren SO (2003) Acquisition,
expression, and reinstatement of ethanol-induced conditioned
place preference in mice: effects of opioid receptor-like 1 receptor
agonists and naloxone. J Pharmacol Exp Ther 304:310318
Kuzmin A, Madjid N, Terenius L, Ogren SO, Bakalkin G (2006)
Big dynorphin, a prodynorphin-derived peptide produces
NMDA receptor-mediated effects on memory, anxiolytic-like
and locomotor behavior in mice. Neuropsychopharmacology
31:19281937
AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y
(2000) The role of the corticotrophin-releasing factor in stress-
induced relapse to alcohol-seeking behavior in rats. Psychophar-
macology 150:317324
Li XC, Karadsheh MS, Jenkins PM, Stitzel JA (2005) Genetic
correlation between free-choice oral consumption of nicotine
and alcohol in C57BL/6J x C3H/HeJ F2 intercross mice. Behav
Brain Res 157:7990
Lindholm S, Werme M, Berne S, Franck J (2001) The selective
κ-opioid receptor U50, 488H attenuates voluntary ethanol
intake in the rat. Behav Brain Res 120:137146
Logrip ML, Janak PH, Ron D (2009) Blockade of ethanol reward by
the kappa opioid receptor agonist U50, 488H. Alcohol 43:359
365
Psychopharmacology
Lowery EG, Sparrow AM, Breese GR, Knapp DJ, Thiele TE (2008)
The CRF-1 receptor antagonist, CP-154, 526, attenuates stress-
induced increases in ethanol consumption by BALB/cJ mice.
Alcohol Clin Exp Res 32:240248
Lucki I, Dalvi A, Mayorga AJ (2001) Sensitivity to the effects of
pharmacologically selective antidepressants in different strains of
mice. Psychopharmacology (Berl) 155:651657
Matsuzawa S, Suzuki T, Misawa M (1998) Conditioned fear stress
induces ethanol-associated place preference in rats. Eur J
Pharmacol 341:127130
Matsuzawa S, Suzuki T, Misawa M, Nagase H (1999) Different roles
of μ-, δ- and κ-opioid receptors in ethanol-associated place
preference in rats exposed to conditioned fear stress. Eur J
Pharmacol 368:916
McKenzie-Quirk SD, Miczek KA (2008) Social rank and social
separation as determinants of alcohol drinking in squirrel
monkeys. Psychopharmacology 201:137145
McLaughlin JP, Marton-Popovici M, Chavkin C (2003) κOpioid
receptor antagonism and prodynorphin gene disruption block
stress-induced behavioral responses. J Neurosci 23:56745683
McLaughlin JP, Land BB, Li S, Pintar JE, Chavkin C (2006) Prior
activation of kappa opioid receptors by U50, 488 mimics forced
swim stress to potentiate cocaine place preference conditioning.
Neuropsychopharmacology 31:787794
Middaugh LD, Bandy A-LE (2000) Naltrexone effects on ethanol
consumption and response to ethanol conditioned cues in C57Bl/
6 mice. Psychopharmacology 151:321327
Mills KC, Bean JW, Hutcheson JS (1977) Shock induced ethanol
consumption in rats. Pharmacol Biochem Behav 6:107115
Mitchell JM, Liang MT, Fields HL (2005) A single injection of the
kappa opioid antagonist norbinaltorphimine increases ethanol
consumption in rats. Psychopharmacology 182:384392
Negus SS (2004) Effects of the kappa opioid agonist U50, 488 and the
kappa opioid antagonist nor-binaltorphimine on choice between
cocaine and food in rhesus monkeys. Psychopharmacology
(Berlin) 176:204213
Nocjar C, Middaugh LD, Tavernetti M (1999) Ethanol consumption
and place-preference conditioning in the alcohol-preferring
C57BL/6 mouse: relationship with motor activity patterns.
Alcohol Clin Exp Res 23:683692
Orsini C, Bonito-Oliva A, Conversi D, Cabib S (2005) Susceptibility
to conditioned place preference induced by addictive drugs in
mice of the C57BL/6 and DBA/2 inbred strains. Psychopharma-
cology 181:327336
Peele S, Brodsky A (2000) Exploring psychological benefits
associated with moderate alcohol use: a necessary corrective to
assessments of drinking outcomes? Drug Alcohol Depend
60:221247
Piazza PV, Deminiere JM, Le Moal M, Simon H (1990) Stress- and
pharmacologically induced behavioral sensitization increases
vulnerability to acquisition of amphetamine self-administration.
Brain Res 514:2226
Pohorecky LA (1981) The interaction of alcohol and stress: a review.
Neurosci Biobehav Rev 5:209229
Risinger FO, Brown MM, Doan AM, Oakes RA (1998) Mouse strain
difference in oral operant ethanol reinforcement under continuous
access conditions. Alcohol Clin Exp Res 22:677684
Roberts AJ, McDonald JS, Heyser CJ, Kieffer BL, Matthes HWD,
Koob GF, Gold LH (2000) μ-opioid receptor knockout mice do
not self-administer alcohol. J Pharmacol Exp Ther 293:1002
1008
Rockman GE, Hall A, Hong J, Glavin GB (1987) Unpredictable cold-
immobilization stress effects voluntary ethanol consumption in
rats. J Life Sci 40:12451251
Shaham Y, Stewart J (1994) Exposure to mild stress enhances the
reinforcing efficacy of intravenous heroin self-administration in
rats. Psychopharmacology (Berl) 114:523527
Sharifi N, Diehl N, Yaswen L, Brennan MB, Hochgeschwender U
(2001) Generation of dynorphin knockout mice. Brain Res Mol
Brain Res 86:7075
Shippenberg TS, Herz A (1986) Differential effects of mu and kappa
opioid systems on motivational processes. NIDA Res Monogr
75:563566
Shippenberg TS, Zapata A, Chefer VI (2007) Dynorphin and the
pathophysiology of drug addiction. Pharmacol Ther 116:306321
Shirayama Y, Ishida H, Iwata M, Hazama GI, Kawahara R, Duman RS
(2004) Stress increases dynorphin immunoreactivity in limbic
brain regions and dynorphin antagonism produces antidepressant-
like effects. J Neurochem 90:12581268
Sommer W, Hyytiä P, Kiianmaa K (2006) The alcohol-preferring AA
and alcohol-avoiding ANA rats: neurobiology of the regulation
of alcohol drinking. Addict Biol 11:289309
Spanagel R, Montkowski A, Allingham K, Stohr T, Shoaib M,
Holsboer F, Landgraf R (1995) Anxiety: a potential predictor of
vulnerability to the initiation of ethanol self-administration in
rats. Psychopharmacology (Berl) 122:369373
Stromberg MF, Casale M, Volpicelli L, Volpicelli JR, O'Brien CP
(1998) A comparison of the effects of the opioid antagonists
naltrexone, naltrindole, and beta-funaltrexamine on ethanol
consumption in the rat. Alcohol 15:281289
Suzuki T, Shiozaki Y, Masukawa Y, Misawa M, Nagase H (1992) The
role of mu- and kappa-opioid receptors in cocaine-induced
conditioned place preference. Jpn J Pharmacol 58:435442
Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND (2005)
Ethanol self-administration and ethanol conditioned place pref-
erence are reduced in mice lacking cannabinoid CB1 receptors.
Behav Brain Res 164:206213
Thiele TE, Marsh DJ, Ste ML, Bernstein IL, Palmiter RD (1998)
Ethanol consumption and resistance are inversely related to
neuropeptide Y levels. Nature 396:366369
van Erp AM, Miczek KA (2001) Persistent suppression of ethanol
self-administration by brief social stress in rats and increased
startle response as index of withdrawal. Physiol Behav 73:301
311
van Erp AM, Tachi N, Miczek KA (2001) Short or continuous social
stress: suppression of continuously available ethanol intake in
subordinate rats. Behav Pharmacol 12:335342
Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neurophar-
macology of alcohol addiction. Br J Pharmacol 154:299315
Walker BM, Koob GF (2008) Pharmacological evidence for a
motivational role of κ-opioid systems in ethanol dependence.
Neuropsychopharmacology 33:643652
Will MJ, Watkins LR, Maier SF (1998) Uncontrollable stress
potentiates morphine's rewarding proprieties. Pharmacol Bio-
chem Beh 60:655664
Willinger U, Lenzinger E, Hornik K, Fischer G, Schonbeck G,
Aschauer HN, Meszaros K, European fluvoxamine in alcoholism
study group (2002) Anxiety as a predictor of relapse in detoxified
alcohol-dependent patients. Alcohol 37:609612
Wilson MA, Burghardt PR, Ford KA, Wilkinson MB, Primeaux SD
(2004) Anxiolytic effects of diazepam and ethanol in two
behavioral models: comparison of males and females. Pharmacol
Biochem Behav 78:445458
Wolffgramm J (1990) Free choice ethanol intake of laboratory rats under
different social conditions. Psychopharmacology 101:233239
Zapata A, Shippenberg TS (2006) Endogenous κopioid receptor
systems modulate the responsiveness of mesoaccumbal dopamine
neurons to ethanol. Alcohol Clin Exp Res 30:592597
Psychopharmacology
... Self-administration or locomotor activity in either exposure condition was not impacted by zyklophin. 30 Sperling RE, Gomes SM, Sypek EI, Carey AN, McLaughlin JP (2010) [45] Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration ...
... The forced swim test (FST) is used to study depression-like behaviors in rodents [51]. Sperling and colleagues showed that nor-BNI lowers the enhanced ethanol intake caused by forced-swim stress, whereas the KOR agonist U50,488 increases ethanol preference and ethanol drinking in mice [45], implying that similar processes are involved in the development of ethanol withdrawal-and KOR agonist-induced behavioral alterations [12]. ...
Article
Full-text available
Alcohol use disorder (AUD) represents major public and socioeconomic issues. Alcohol exerts its pharmacological effects by altering different neurotransmitter systems, such as g-aminobutyric acid (GABA), glutamate, opioids, etc. Recent evidence suggests that the dynorphin (DYN)/kappa opioid receptor (KOR) system mediates the negative affective states associated with alcohol withdrawal. This system is also involved in stress-mediated alcohol intake in alcohol-dependent subjects. The DYN/KOR system probably exerts its action in the central nucleus of the amygdala (CeA) to mediate the negative affective states associated with alcohol withdrawal. This article aims to review the current literature regarding the role of the DYN/KOR system in the actions of alcohol. We first review the literature regarding the effect of alcohol on the level of the peptide and its receptor, and the role of the endogenous DYN/KOR system in alcohol reward and negative affective states associated with alcohol withdrawal is then discussed. We also review the literature regarding the effects of KOR ligands on these processes.
... In addition, the CNS regional specificity for the nor-BNI actions was suggested, with NAc injections being more effective in producing antidepressant effects than hippocampal (115,116). Finally, although nor-BNI applied before physical stress or social defeat stress blocked behavioral despair (92,93), anxiety (79), and drug-seeking behaviors in rodents (76,117), there are also reports indicating no effect of KOP antagonists on already established behavioral deficits (17). ...
Article
Major depressive disorder (MDD) afflicts approximately 5 % of the world population, and about 30–50 % of patients who receive classical antidepressant medications do not achieve complete remission (treatment resistant depressive patients). Emerging evidence suggests that targeting opioid receptors mu (MOP), kappa (KOP), delta (DOP), and the nociceptin/orphanin FQ receptor (NOP) may yield effective therapeutics for stress-related psychiatric disorders. As depression and pain exhibit significant overlap in their clinical manifestations and molecular mechanisms involved, it is not a surprise that opioids, historically used to alleviate pain, emerged as promising and effective therapeutic options in the treatment of depression. The opioid signaling is dysregulated in depression and numerous preclinical studies and clinical trials strongly suggest that opioid modulation can serve as either an adjuvant or even an alternative to classical monoaminergic antidepressants. Importantly, some classical antidepressants require the opioid receptor modulation to exert their antidepressant effects. Finally, ketamine, a well-known anesthetic whose extremely efficient antidepressant effects were recently discovered, was shown to mediate its antidepressant effects via the endogenous opioid system. Thus, although opioid system modulation is a promising therapeutical venue in the treatment of depression further research is warranted to fully understand the benefits and weaknesses of such approach.
... Similarly, in male mice drinking EtOH under a drinking-in-the-dark paradigm, systemic injection with U50, at doses from 1-6 mg/kg but not 10 mg/kg, stimulated binge-like EtOH but not sucrose drinking (Anderson et al., 2019;Rose et al., 2016). While the same higher dose of U50 (10 mg/kg) was found to stimulate EtOH intake in male mice given two-bottle free choice continuous access to EtOH when injected prior to 24-h access (Sperling et al., 2010), it in fact reduced EtOH drinking in male Lewis rats given 2-h daily access (drinking ~0.55 g/kg/2 h), when injected 15 min prior to the test (Lindholm et al., 2001). Similarly, this higher dose as well as lower doses reduced both EtOH and sucrose drinking in male Long-Evans and alcohol-preferring (P) rats given 20 min daily access (drinking 0.6-1.2 ...
Article
Full-text available
The dynorphin (DYN)/kappa opioid receptor (KOR) system has increasingly been investigated as a possible pharmacotherapeutic target for alcohol use disorder, but findings on the direction of its effects have been mixed. Activation of KORs by DYN has been shown to elicit dysphoric effects, and the DYN/KOR system has canonically been considered particularly important in driving alcohol intake through negative reinforcement in dependent states. However, this review also highlights its activity in opposing the positive reinforcement that drives alcohol intake at earlier stages. Both DYN and KORs are concentrated in the extended amygdala, a set of interconnected regions that includes the bed nucleus of the stria terminalis, central nucleus of the amygdala, and nucleus accumbens shell. This review focuses on the role of the DYN/KOR system in the extended amygdala in ethanol use. It begins by examining the effects of ethanol on the expression of DYN/KOR in the extended amygdala, expression of DYN/KOR in alcohol‐preferring and alcohol‐avoiding animals, and the effects of knocking out DYN/KOR genes on ethanol intake. Then, it examines the effects on ethanol use in both dependent and nondependent states from systemic pharmacological manipulations of DYN/KOR and from specific manipulation of this system in regions of the extended amygdala. We propose that greater expression and binding of DYN/KOR, by reducing the positive reinforcement that drives early stages of intake, initially acts to prevent the escalation of ethanol drinking. However, prolonged, binge‐like, or intermittent ethanol intake enhances levels of DYN/KOR in the extended amygdala such that the system ultimately facilitates the negative reinforcement that drives later stages of ethanol drinking. This review highlights the potential of the DYN/KOR system as a target that can affect different outcomes across different stages of ethanol drinking and the development of alcohol use disorder.
... Dynorphin's activation decreases dopamine release and is an important marker of reward and motivated behavior. Activation of dynorphin and substance P codes for stress response and has also been shown to potentiate stress-induced drug-seeking behavior [26]. As drug-seeking behavior relates to the sensitivity to natural rewards, this supports that MP+FLX augments sucrose sensitivity [12,25]. ...
Article
Background: Attention Deficit Hyperactivity Disorder (ADHD) can be comorbid with depression, often leading to prescription of both methylphenidate (MP) and selective serotonin reuptake inhibitor (SSRI) antidepressants, such as fluoxetine (FLX). Moreover, these drugs are often misused as a cognitive enhancer. This study examined the effects of chronic oral co-administration of MP and FLX on depressive- and anxiety-like behaviors. Methods: Adolescent rats received daily either water (control), MP, FLX, or the combination of MP plus FLX in their drinking water over the course of 4 weeks. Results: Data analysis show a decrease in food consumption and body weight for rats exposed to FLX or the combination of MP and FLX. Sucrose consumption was significantly greater in FLX or MP+FLX groups as compared to controls. FLX treated rats showed no effect in the elevated plus maze (EPM; open arm time) and forced swim test (FST; latency to immobility). However, rats treated with the combination (MP+FLX) showed significant anxiolytic-like and anti-depressive-like behaviors (as measured by EPM and FST), as well as significant increases in overall activity (distance traveled in open field test). Finally, the combined MP+FLX treatment induced a decrease in anxiety and depressive-like behaviors that was significantly greater than the response from either of these two drugs alone. Conclusion: These behavioral results characterize the long-term effects of these drugs (orally administered) that are widely co-administered and co-misused and provide important insight into the potential neurobiological and neurochemical effects. Future research will determine the potential risks of the long-term use of MP and FLX together.
... The forced swim test (FST) is used to study depression-like behaviors in rodents [44]. Sperling and colleagues showed that nor-BNI lowers the enhanced ethanol intake caused by forced-swim stress, whereas the KOR agonist U50,488 increases ethanol preference and ethanol drinking in mice [45], implying that similar processes are involved in the development of ethanol withdrawal-and KOR agonist-induced behavioral alterations [12]. ...
Preprint
Alcohol use disorder (AUD) represents major public and socioeconomic issues. Alcohol exerts its phar-macological effects by altering different neurotransmitter systems, such as g-aminobutyric acid (GABA), glutamate, opioids, etc. Recent evidence suggests that the dynorphin (DYN)/kappa opioid receptor (KOR) system mediates the negative affective states associated with alcohol withdrawal. This system is also in-volved in stress-mediated alcohol intake in alcohol-dependent subjects. The DYN/KOR system probably exerts its action in the central nucleus of the amygdala (CeA) to mediate the negative affective states as-sociated with alcohol withdrawal. This article aims to review the current literature regarding the role of the DYN/KOR system in the actions of alcohol. We first review the literature regarding the effect of alcohol on the level of the peptide and its receptor, and the role of the endogenous DYN/KOR system in alcohol reward and negative affective states associated with alcohol withdrawal is then discussed. We also review the literature regarding the effects of KOR ligands on these processes.
Article
Full-text available
Prior studies examining the effects of cocaine on the dynorphin/kappa opioid receptor (Dyn/KOR) system primarily focus on non-contingent cocaine exposure, but the effects of self-administration, which more closely reflects human drug-taking behaviors, are not well studied. In this study we characterized the effects of escalated intravenous cocaine self-administration on the functional state of the Dyn/KOR system and its interaction with mesolimbic dopamine signaling. Rats self-administered cocaine in an extended access, limited intake cocaine procedure, in which animals obtained 40 infusions per day (1.5 mg/kg/inf) for 5 consecutive days to ensure comparable consumption levels. Following single day tests of cue reactivity and progressive ratio responding, quantitative real-time polymerase chain reaction was used to measure levels of Oprk and Pdyn transcripts in the ventral tegmental area and nucleus accumbens. Additionally, after self-administration, ex vivo fast-scan cyclic voltammetry in the NAc was used to examine the ability of the KOR agonist U50,488 to inhibit dopamine release. We found that KOR-induced inhibition of dopamine release was enhanced in animals that self-administered cocaine compared to controls, suggesting upregulated Dyn/KOR activity after cocaine self-administration. Furthermore, expression levels of Pdyn in the nucleus accumbens and ventral tegmental area, and Oprk in the nucleus accumbens, were elevated in cocaine animals compared to controls. Additionally, Pdyn expression in the nucleus accumbens was negatively correlated with progressive ratio breakpoints, a measure of motivation to self-administer cocaine. Overall, these data suggest that cocaine self-administration elevates KOR/Dyn system activity in the mesolimbic dopamine pathway.
Article
The opioid G-protein coupled receptors (GPCRs) strongly modulate many of the central nervous system structures that contribute to major neurological and psychiatric disorders including pain, major depressive disorder (MDD), and substance use disorders (SUDs). To better treat these and related diseases, it is essential to understand the signaling of their endogenous ligands. In this review, we focus on what is known and unknown about the regulation of the over two dozen endogenous peptides with high affinity for one or more of the opioid receptors. We briefly describe which peptides are produced, with a particular focus on the recently proposed possible synthesis pathways for the endomorphins. Next, we describe examples of endogenous opioid peptide expression organization in several neural circuits and how they appear to be released from specific neural compartments that vary across brain regions. We discuss current knowledge regarding the strength of neural activity required to drive endogenous opioid peptide release, clues about how far peptides diffuse from release sites, and their extracellular lifetime after release. Finally, as a translational example, we discuss the mechanisms of action of naltrexone (NTX), which is used clinically to treat AUD. NTX is a synthetic morphine analog that non-specifically antagonizes the action of most endogenous opioid peptides developed in the 1960s and FDA approved in the 1980s. We review recent studies clarifying the precise endogenous activity that NTX prevents. Together, the works described here highlight the challenges and opportunities the complex opioid system presents as a therapeutic target.
Article
Immediately following spinal cord injury (SCI) patients experience pain, associated with injury to the spinal cord and nerves as well as accompanying peripheral injuries. This pain is usually treated with opioids, and most commonly with morphine. However, in a rodent model we have shown that, irrespective of the route of administration, morphine administered in the acute phase of SCI undermines long-term locomotor recovery. Our previous data suggests that activation of kappa opioid receptors (KORs) mediate these negative effects. Blocking KORs with nor-Binaltorphimine (norBNI), prior to a single dose of epidural morphine, prevented the morphine-induced attenuation of locomotor recovery. Because numerous cellular changes occur with chronic opioid administration compared to a single dose, the current study tested whether norBNI was also effective in a more clinically relevant paradigm of repeated, intravenous morphine administration after SCI. We hypothesized that blocking KOR activation during repeated, intravenous morphine administration would also protect recovery. Supporting this hypothesis, we found that blocking KOR activation in young, male rats prevented the negative effects of morphine on locomotor recovery, although neither norBNI nor morphine had an effect on long-term pain at the doses used. We also found that norBNI treatment blocked the adverse effects of morphine on lesion size. These data suggest that a KOR antagonist given in conjunction with morphine may provide a clinical strategy for effective analgesia without compromising locomotor recovery after SCI.
Article
Full-text available
Ethanol place-preference conditioning (PC) was conducted in drug-naive and ethanol pre-exposed female and male C57BL/6J (C57) mice to assess whether environmental cues can develop positive incentive value for ethanol-preferring animals when associated with administration of ethanol. After 12 days episodic access to free-choice ethanol and/or water self-administration, mice received eight ethanol injections (1.75 g/kg/ip) 5 min before placement in their nonpreferred PC chamber and eight saline injections paired with their preferred chamber. Control mice received eight saline injections (20 ml/kg) in both their preferred and nonpreferred chambers. Mice of both sexes developed strong ethanol PC. Correlational analysis indicated that the strength of ethanol PC for mice with a prior ethanol drinking experience was inversely related to the amount of ethanol consumed regardless of gender. Furthermore, depending on gender and previous ethanol drinking experience, ethanol PC was differentially related to initial baseline motor activity, the initial motor response to ethanol, or rapid change in the motor response to ethanol. Thus, a complicated relationship between neural systems that mediate ethanol reward and motor activity may exist as suggested by current addiction theory.
Article
Full-text available
Rationale: Intermittent footshock stress reliably reinstates extinguished alcohol-taking behavior in drug-free rats, but the neurochemical events involved in this effect are not known. Objective: We studied here whether two main modulators of stress responses, corticotropin-releasing factor (CRF) and corticosterone, are involved in reinstatement of alcohol seeking induced by the intermittent footshock stressor. Methods: Rats were given alcohol in a two-bottle choice procedure (water versus alcohol) for 30 days and were then trained for 60min per day to press a lever for alcohol (12% w/v) for 24–30 days in operant conditioning chambers. After stable drug-taking behavior was obtained, lever pressing for alcohol was extinguished by terminating drug delivery for 5–8 days. Reinstatement of alcohol seeking was then determined after exposure to intermittent footshock (0.8mA; 10min) in different groups of rats that were pretreated with CRF receptor antagonists or underwent adrenalectomy (ADX) to remove endogenous corticosterone from the body. Results: The CRF receptor antagonists, d-phe-CRF (0.3 or 1.0µg; ICV) and CP-154,526 (15, 30 or 45mg/kg; IP) attenuated footshock-induced reinstatement of alcohol seeking in a dose dependent manner. In contrast, the removal of circulating corticosterone by ADX had no effect on footshock stress-induced reinstatement of alcohol-taking behavior. In addition, the prevention of the footshock-induced rise in corticosterone while maintaining basal levels of the hormone by providing adrenalectomized rats with corticosterone pellets (50mg/kg per day), had no effect on stress-induced reinstatement. Conclusions: These data suggest that CRF contributes to stress-induced relapse to alcohol seeking via its actions on extra-hypothalamic sites. The present data, and previous data with heroin- and cocaine-trained rats, point to a general role of CRF in relapse to drugs induced by stressors.
Article
Previous studies have demonstrated that stress may increase prodynorphin gene expression, and κ opioid agonists suppress drug reward. Therefore, we tested the hypothesis that stress-induced release of endogenous dynorphin may mediate behavioral responses to stress and oppose the rewarding effects of cocaine. C57Bl/6 mice subjected to repeated forced swim testing (FST) using a modified Porsolt procedure at 30°C showed a characteristic stress-induced immobility response and a stress-induced analgesia observed with a tail withdrawal latency assay. Pretreatment with the κ opioid receptor antagonist nor-binaltorphimine (nor-BNI; 10 mg/kg, i.p.) blocked the stress-induced analgesia and significantly reduced the stress-induced immobility. The nor-BNI sensitivity of the behavioral responses suggests an activation of the κ opioid receptor by a stress-induced release of dynorphin peptides. Supporting this hypothesis, transgenic mice possessing a disrupted prodynorphin gene showed no increase in immobility or stress-induced analgesia after exposure to repeated FST. Because both stress and the κ opioid system can modulate the response to drugs of abuse, we tested the effects of forced swim stress on cocaine-conditioned place preference (CPP). FST-exposed mice conditioned with cocaine (15 mg/kg, s.c.) showed significant potentiation of place preference for the drug-paired chamber over the responses of unstressed mice. Surprisingly, nor-BNI pretreatment blocked stress-induced potentiation of cocaine CPP. Consistent with this result, mice lacking the prodynorphin gene did not show a stress-induced potentiation of cocaine CPP, whereas wild-type littermates did. The findings suggest that chronic swim stress may activate the κ opioid system to produce analgesia, immobility, and potentiation of the acute rewarding properties of cocaine in C57Bl/6 mice.
Article
Rationale: In previous studies, we have demonstrated that mice of the inbred strain C57BL/6J (C57) are more susceptible to amphetamine-induced conditioned place preference (CPP) than DBA/2J (DBA) mice. Moreover, we also observed parallel strain differences for the locomotor-stimulant effects of the drug. However, other studies have reported either no difference or opposite strain differences for cocaine- and morphine-induced CPP as well as for the locomotor effects of these drugs, suggesting that amphetamine-related behavioral phenotypes might depend on a specific pharmacological action of the psychostimulant. Objectives: This study was aimed at testing strain differences for cocaine- and morphine-related behavioral phenotypes in the same experimental protocol and conditions previously used for amphetamine. Methods: C57 and DBA mice were tested for CPP induced by cocaine (0, 5, 10, and 20 mg/kg) and morphine (0, 5, 7.5, and 10 mg/kg). Locomotor activity data were simultaneously obtained by measuring distance moved during all different CPP phases and unconditioned locomotor activity, behavioral sensitization and conditioned hyperactivity were measured together with CPP. Results: (a) Either cocaine or morphine promoted significant CPP at lower doses in C57 than in DBA mice; (b) only drug-trained C57 mice showed a significant CPP compared with the control group; and (c) only C57 mice showed dose-dependent effects of cocaine on CPP. Moreover, there was no relationship between drug-induced CPP and locomotion. Conclusions: The results demonstrate that C57 and DBA mice differ in their sensitivity to cocaine- and morphine-induced CPP and suggest that the two strains differ in sensitivity to the positive incentive properties of drugs of abuse.
Article
Genetic linkage analysis of rats that were selectively bred for alcohol preference identified a chromosomal region that includes the neuropeptide Y (NPY) gene. Alcohol-preferring rats have lower levels of NPY in several brain regions compared with alcohol-non-preferring rats. We therefore studied alcohol consumption by mice that completely lack NPY as a result of targeted gene disruption. Here we report that NPY-deficient mice show increased consumption, compared with wild-type-mice, of solutions containing 65, 10% and 20% (v/v) ethanol. NPY-deficient mice are also less sensitive to the sedative/hypnotic effects of ethanol, as shown by more rapid recovery from ethanol-induced sleep, even though plasma ethanol concentrations do not differ significantly from those of controls. In contrast, transgenic mice that overexpress a marked NPY gene in neurons that usually express it have a lower preference for ethanol and are more sensitive to the sedative/hypnotic effects of this drug than controls. These data are direct evidence that alcohol consumption and resistance are inversely related to NPY levels in the brain.
Article
Rationale: Recent advances in neurobehavioral genetics have increased the importance of research on the behavioral patterns of different mouse strains. A comprehensive comparison of inbred and outbred mouse strains was conducted to provide information on the range of performance and pharmacological effects in the forced swimming test, a behavioral test commonly used to measure the effects of antidepressant drugs. Objectives: Baseline performance and pharmacological responses to desipramine, a selective norepinephrine reuptake inhibitor, and fluoxetine, a selective serotonin reuptake inhibitor, were compared in seven inbred and four outbred mouse strains in the forced swimming test. Methods: Swim sessions were conducted by placing mice in individual glass cylinders filled with water for 6min. The duration of behavioral immobility during the last 4min of the test was scored from videotapes. Results: A 10-fold range of immobility values and coefficient of variation supported the existence of substantial behavioral differences between mouse strains in baseline performance in the FST. In general, inbred strains demonstrated lower variability than outbred strains. Desipramine dose-dependently reduced immobility in seven of the 11 strains tested, with DBA/2J and the C57BL/6J mice showing greater sensitivity than the other strains. In contrast, fluoxetine reduced immobility in only three out of the 11 strains tested, DBA/2J, BALB/cJ and NIH Swiss mice. Conclusions: Background strain is a critical variable in determining baseline performance and the sensitivity to different types of antidepressant drugs in the mouse FST. The use of such mouse strains may provide information on the genetic basis for strain differences in depressive behavior and differential sensitivity to diverse classes of antidepressants.
Article
Rationale: The conditions under which naltrexone reduces ethanol consumption and its effect on behavior controlled by ethanol conditioned stimuli remain unclear. Objectives: The objectives were to determine the effects of naltrexone on ethanol consumption by C57BL/6 (B6) mice when injected subcutaneously (expt 1) or delivered by osmotic minipump (expt 2), and on ethanol conditioned cues (expt 3). Methods: Naltrexone effects on ethanol consumption and preference were measured in a continuous access two-bottle choice paradigm in groups of mice implanted with osmotic minipumps delivering 0–3.0mg/kg per day or injected subcutaneously with 0–6.0mg/kg doses. Naltrexone's (0–3.0mg/kg) effect on ethanol-conditioned cues was indexed by its effect on the expression of ethanol place conditioning (expt 3). Results: Naltrexone produced a transient reduction in ethanol consumption and a consistent reduction in preference when injected; however, it had no effect on ethanol consumption or preference when delivered continuously by osmotic minipump. Naltrexone attenuated the expression of ethanol place conditioning in a U-shaped dose-response function. Conclusions: The transient reduction in ethanol consumption produced by injected naltrexone and the absence of an effect when continuously delivered confirms a report that maintaining naltrexone at steady state levels may antagonize its attenuation of ethanol consumption. The reduced expression of ethanol place conditioning in naltrexone-injected mice suggests that the drug can attenuate the reinforcing effects of ethanol conditioned stimuli as was recently reported for lever responding maintained by ethanol conditioned stimuli in rats. These effects were observed at naltrexone doses with no readily apparent adverse side-effects, supporting its usefulness for treating alcoholism.
Article
Strategies used to explore the role of stressors in drug addiction include measuring stressor’s effects on drug’s rewarding properties. The current investigation explored the effect of an acute stressor on morphine conditioned place preference. Twenty-four hours following either inescapable tail shock or home-cage control treatment, all subjects were conditioned with morphine (0, 1, 2, and 3 mg/kg SC) over 2 days, and later tested for conditioned place preference. Inescapably shocked subjects demonstrated a potentiated place preference compared to controls. The inescapable shock-induced potentiated place preference developed even when conditioning was delayed until 6 and 7 days following the stressor, while no longer occurring after a 14- and 15-day interval. The potentiation was not a result of reduced locomotion in the inescapably shocked subjects, as activity in inescapably shocked and home-cage control subjects was the same following “mock” saline conditioning. Furthermore, the anxiogenic methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM) (0.3 mg/kg IP), which produces effects similar to those produced by inescapable shock, also potentiated morphine place preference. In addition, the potentiation in inescapably shocked subjects was dependent upon the stressor’s uncontrollability, as identical escapable shock did not potentiate place preference above control subjects. Finally, the inescapable shock-induced potentiated place preference was drug specific, as amphetamine place preference was not affected.